Trial intelligence / Profile preview

Intrathecal morphine 50 vs 100 μg plus very low-dose naloxone for cesarean section pain and complications

IRCT20091219002883N6Phase 3Completed

Sponsor
Mazandaran University of Medical Sciences
Start
Oct 2021
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of morphine and naloxone in postoperative pain (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoints: pain_intensity and intrathecal_complications. Started Oct 2021; status: completed.

02

Drugs

morphinenaloxone
03

Conditions

postoperative pain

Beyond the preview

Go deeper on IRCT20091219002883N6.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20091219002883N6.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call